The relationship between multiple plasma biomarker levels and renal disease activity in Fabry disease

被引：0
|
作者：
Seyda Gul Ozcan [1 ]
Necmi Eren [2 ]
Mevlut Tamer Dincer [1 ]
Zeynep Atli [3 ]
Murat Bolayirli [4 ]
Metin Ergul [2 ]
Hakan Ozer [5 ]
Kultigin Turkmen [5 ]
Sinan Trabulus [1 ]
Nurhan Seyahi [1 ]
机构：
[1] Istanbul University- Cerrahpasa,Cerrahpasa Medical Faculty, Department of Nephrology
[2] Kocaeli University,Kocaeli Medical Faculty, Department of Nephrology
[3] Sinop University,Deparment of Accounting and Taxation
[4] Istanbul University- Cerrahpasa,Cerrahpasa Medical Faculty, Department of Biochemistry
[5] Necmettin Erbakan University,Meram Medical Faculty, Department of Nephrology
来源：
BMC Nephrology | / 26卷 / 1期
关键词：
Fabry disease; Plasma biomarkers; Genetic kidney disease;
D O I：
10.1186/s12882-025-04189-x
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Plasma globotriaosylsphingosine as a biomarker of Fabry disease
    Togawa, Tadayasu
    Kodama, Takashi
    Suzuki, Toshihiro
    Sugawara, Kanako
    Tsukimura, Takahiro
    Ohashi, Toya
    Ishige, Nobuyuki
    Suzuki, Ken
    Kitagawa, Teruo
    Sakuraba, Hitoshi
    MOLECULAR GENETICS AND METABOLISM, 2010, 100 (03) : 257 - 261
  • [2] Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma
    Pagni, Fabio
    Pieruzzi, Federico
    Zannella, Stefano
    Di Giacomo, Antonella
    Bovo, Giorgio
    Ferrario, Franco
    Torti, Giacomo
    Rivera, Rodolfo
    Assi, Emma
    Viglione, Federica
    Nebuloni, Manuela
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (06) : 537 - 541
  • [3] Is globotriaosylceramide a useful biomarker in Fabry disease?
    Young, E
    Mills, K
    Morris, P
    Vellodi, A
    Lee, P
    Waldek, S
    Winchester, B
    ACTA PAEDIATRICA, 2005, 94 : 51 - 54
  • [4] Fabry disease in a renal allograft
    Puliyanda, DP
    Wilcox, WR
    Bunnapradist, S
    Nast, CC
    Jordan, SC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) : 1030 - 1032
  • [5] Renal Complications of Fabry Disease
    Basic-Jukic, Nikolina
    Kes, Petar
    Coric, Marijana
    Basic-Kes, Vanja
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 6046 - 6050
  • [6] Plasma adiponectin is a potential biomarker for organ involvement in male Fabry disease patients
    Hovakimyan, Marina
    Talabattula, Venkata Ajay Narendra
    Cozma, Claudia
    Beetz, Christian
    Rolfs, Arndt
    Elstein, Deborah
    BLOOD CELLS MOLECULES AND DISEASES, 2020, 80
  • [7] Deficient α-galactosidase A activity in plasma but no Fabry disease -: a pitfall in diagnosis
    Hoffmann, B
    Koch, HG
    Schweitzer-Krantz, S
    Wendell, U
    Mayatepek, E
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (11) : 1276 - 1277
  • [8] Clinical significance of plasma globotriaosylsphingosine levels in Chinese patients with Fabry disease
    Ouyang, Yan
    Chen, Bing
    Pan, Xiaoxia
    Wang, Zhaohui
    Ren, Hong
    Xu, Yaowen
    Ni, Liyan
    Yu, Xialian
    Yang, Li
    Chen, Nan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (04) : 3733 - 3742
  • [9] Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease
    Togawa, Tadayasu
    Kawashima, Ikuo
    Kodama, Takashi
    Tsukimura, Takahiro
    Suzuki, Toshihiro
    Fukushige, Tomoko
    Kanekura, Takuro
    Sakuraba, Hitoshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 399 (04) : 716 - 720
  • [10] RENAL INVOLVEMENT IN PAEDIATRIC FABRY DISEASE
    Sestito, S.
    Falvo, F.
    Sallemi, A.
    Petrisano, M.
    Scuderi, M. G.
    Tarsitano, F.
    D'Angelo, G.
    Betta, P.
    Roppa, K.
    Parisi, F.
    Pensabene, L.
    Fede, C.
    Chimenz, R.
    Concolino, D.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (05) : 59 - 63
12345